Next Article in Journal
The Roles of MicroRNA in Lung Cancer
Previous Article in Journal
An Acid Up-Regulated Surface Protein of Lactobacillus paracasei Strain GCRL 46 is Phylogenetically Related to the Secreted Glucan- (GpbB) and Immunoglobulin-Binding (SibA) Protein of Pathogenic Streptococci
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Growth Hormone Receptor Gene is Essential for Chicken Mitochondrial Function In Vivo and In Vitro

1
Department of Animal Genetics, Breeding and Reproduction, College of Animal Science, South China Agricultural University, Guangzhou 510642, China
2
Guangdong Provincial Key Lab of AgroAnimal Genomics and Molecular Breeding and Key Lab of Chicken Genetics, Breeding and Reproduction, Ministry of Agriculture, Guangzhou 510642, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(7), 1608; https://doi.org/10.3390/ijms20071608
Submission received: 7 March 2019 / Revised: 27 March 2019 / Accepted: 28 March 2019 / Published: 31 March 2019
(This article belongs to the Section Molecular Biology)

Abstract

:
The growth hormone receptor (GHR) gene is correlated with many phenotypic and physiological alternations in chicken, such as shorter shanks, lower body weight and muscle mass loss. However, the role of the GHR gene in mitochondrial function remains unknown in poultry. In this study, we assessed the function of mitochondria in sex-linked dwarf (SLD) chicken skeletal muscle and interfered with the expression of GHR in DF-1 cells to investigate the role of the GHR gene in chicken mitochondrial function both in vivo and in vitro. We found that the expression of key regulators of mitochondrial biogenesis and mitochondrial DNA (mtDNA)-encoded oxidative phosphorylation (OXPHOS) genes were downregulated and accompanied by reduced enzymatic activity of OXPHOS complexes in SLD chicken skeletal muscle and GHR knockdown cells. Then, we assessed mitochondrial function by measuring mitochondrial membrane potential (ΔΨm), mitochondrial swelling, reactive oxygen species (ROS) production, malondialdehyde (MDA) levels, ATP levels and the mitochondrial respiratory control ratio (RCR), and found that mitochondrial function was impaired in SLD chicken skeletal muscle and GHR knockdown cells. In addition, we also studied the morphology and structure of mitochondria in GHR knockdown cells by transmission electron microscopy (TEM) and MitoTracker staining. We found that knockdown of GHR could reduce mitochondrial number and alter mitochondrial structure in DF-1 cells. Above all, we demonstrated for the first time that the GHR gene is essential for chicken mitochondrial function in vivo and in vitro.

1. Introduction

Mitochondria are dynamic organelles with a crucial role in cellular energy homeostasis and metabolism, with the generation of adenosine triphosphate (ATP) through the respiratory chain (RC) being one of their main functions [1]. The RC is composed of four complexes (I–IV) embedded in the inner mitochondrial membrane which are uniquely controlled by mitochondrial DNA (mtDNA) and the nuclear genome [2]. Similar to mammalian mtDNA, chicken mtDNA determines 37 gene products, of which 13 are oxidative phosphorylation (OXPHOS) subunits (complex I, III, IV and V) [3]. In addition, mitochondrial biogenesis is essential for its function, which is mainly regulated by nuclear genes through the PGC1α–NRF1–TFAM signaling pathway [4]. Peroxisome proliferator-activated receptor γ co-activator 1α (PGC1α), the master regulator of mitochondrial biogenesis, can activate the expression of nuclear respiratory factor-1 (NRF1) and mitochondrial transcription factor A (TFAM) to regulate mtDNA replication and transcription in mammals [5].
Growth hormone (GH) and growth hormone receptor (GHR) come together in the GH–GHR–IGF1 signaling pathway to influence mitochondrial function in mammals. Growth hormone can regulate mitochondrial function through the Box 1 region of the GHR gene in CHO cells [6], and several alterations in OXPHOS complexes have been observed in GH-deficient Ames mice [7]. Knockout of GHR (GHRKO) in mice could also alter the expression of key regulators of mitochondrial biogenesis [8,9]. Furthermore, previous studies have reported that insulin-like growth factor 1 (IGF1) signaling can regulate mitochondrial biogenesis markers in the steroidogenic cells of prepubertal testis [10], and is essential for mitochondrial biogenesis in cancer cells [11]. These findings suggest that the GHR gene plays a pivotal role in mammalian mitochondrial function both in vivo and in vitro.
Sex-linked dwarf (SLD) chickens, which are characterized by diverse mutations in GHR [12], are feasible models for understanding the role of GHR in poultry [13]. Previous studies have reported that these mutations in GHR can result in many phenotypic and physiological alterations in chicken, such as shorter shanks, lower body weight and muscle mass loss [14,15,16]. However, the role of GHR in mitochondrial function in poultry remains unknown.
Based on the abovementioned findings, we assessed the function of mitochondria in SLD chicken skeletal muscle and interfered with the expression of GHR in DF-1 cells to investigate the role of GHR in chicken mitochondrial function both in vivo and in vitro. Here, we demonstrate for the first time that GHR is essential for chicken mitochondrial function both in vivo and in vitro.

2. Results

2.1. Low Expression of Key Regulators of Mitochondrial Biogenesis and mtDNA-Encoded OXPHOS Genes in SLD Chicken Skeletal Muscle

In this study, we first assessed the relative mRNA expression of genes involved in the GH–GHR–IGF1 signaling pathway by qRT-PCR. The relative mRNA levels of the GH gene were not significantly different, however, for GHR and IGF1, were significantly downregulated in SLD chicken skeletal muscle compared with normal chicken skeletal muscle, indicating the low level of GH binding activity in SLD chicken skeletal muscle (Figure 1A). In order to investigate the role of GHR in mitochondrial biogenesis in vivo, we assessed the relative mRNA expression of the genes involved in the PGC1α–NRF1–TFAM signaling pathway using qRT-PCR. We found the relative mRNA expression of PGC1α, NRF1, and TFAM to all be significantly downregulated in SLD chicken skeletal muscle compared with normal chicken skeletal muscle (Figure 1B), indicating an inhibition of mitochondrial biogenesis in SLD chicken skeletal muscle. Since TFAM can regulate the transcription of mtDNA, we then determined the relative mRNA expression of mtDNA-encoded OXPHOS genes. We found that the expression of mtDNA-encoded OXPHOS genes was also downregulated in SLD chicken skeletal muscle compared with normal chicken skeletal muscle, indicating that mtDNA transcription was inhibited in SLD chicken skeletal muscle; however, we did not observe a significant difference in CYTB expression (Figure 1C). Taken together, we found low expression of key regulators of mitochondrial biogenesis and mtDNA-encoded OXPHOS genes in SLD chicken skeletal muscle.

2.2. Reduced Enzymatic Activity of OXPHOS Complexes in SLD Chicken Skeletal Muscle

To investigate the role of GHR on the enzymatic activity of OXPHOS proteins in vivo, we assessed the enzymatic activity of OXPHOS complexes in SLD chicken skeletal muscle. We found that the enzymatic activities of OXPHOS complex I, II, III and IV were significantly reduced by 26%, 45%, 53% and 72% in SLD chicken skeletal muscle compared with normal chicken skeletal muscle, respectively (Figure 2A–D), indicating the reduced enzymatic activity of OXPHOS complexes in SLD chicken skeletal muscle.

2.3. Impaired Mitochondrial Function in SLD Chicken Skeletal Muscle

To further investigate the role of GHR in chicken mitochondrial function in vivo, we assessed mitochondrial function in SLD and normal chicken skeletal muscle by measuring mitochondrial membrane potential (ΔΨm), mitochondrial swelling, reactive oxygen species (ROS) production, malondialdehyde (MDA) levels, ATP levels, and the mitochondrial respiratory control ratio (RCR). ΔΨm was significantly reduced (Figure 3A) and accompanied by a significant increase of mitochondrial swelling (Figure 3B) in SLD chicken skeletal muscle compared with normal chicken skeletal muscle. Reactive oxygen species production was significantly increased (Figure 3C) and accompanied by a significant increase of MDA level (Figure 3D) and a significant reduction of ATP level (Figure 3E) in SLD chicken skeletal muscle compared with normal chicken skeletal muscle. Consistently, RCR was significantly reduced in SLD chicken skeletal muscle compared with normal chicken (Figure 3F). Results showed that mitochondrial function in SLD chicken skeletal muscle was impaired.

2.4. Knockdown of GHR Downregulated the Expression of Key Regulators of Mitochondrial Biogenesis and mtDNA-Encoded OXPHOS Genes in DF-1 Cells

In order to determine the role of GHR in chicken mitochondrial function in vitro, we interfered with the expression of GHR in DF-1 cells. Transfection efficiency was measured by the fluorescence intensity of FAM siRNA and qRT-PCR. The expression of the GHR gene was significantly downregulated in GHR knockdown cells, indicating that we had successfully interfered with the expression of the GHR gene in DF-1 cells (Figure 4A,B). Then, we detected the relative mRNA expression of the genes involved in the GH–GHR–IGF1 signaling pathway. We found that the expression of GH was not significantly different in GHR knockdown cells, however, the expression of IGF1 was significantly downregulated in GHR knockdown cells, indicating the low level of GH binding activity in GHR knockdown cells (Figure 4B). In order to investigate the role of GHR in mitochondrial biogenesis in vitro, we then detected the expression of key regulators of mitochondrial biogenesis and mtDNA-encoded OXPHOS genes in DF-1 cells. PGC1α, NRF1, TFAM, and mtDNA-encoded OXPHOS genes were all downregulated in GHR knockdown cells, but we did not observe a significant difference in ND6 and ATP8 expression (Figure 4C,D). Taken together, we demonstrated that knockdown of GHR downregulated the expression of key regulators of mitochondrial biogenesis and mtDNA-encoded OXPHOS genes in DF-1 cells.

2.5. Knockdown of GHR Reduced the Enzymatic Activity of OXPHOS Complexes in DF-1 Cells

In order to investigate whether the knockdown of GHR could alter the enzymatic activities of OXPHOS proteins in DF-1 cells, we assessed the enzymatic activity of OXPHOS complexes at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. The enzymatic activities of OXPHOS complex I, II, III and IV were significantly reduced by 53%, 34%, 36% and 25% in GHR knockdown cells, respectively (Figure 5A–D), indicating that the knockdown of GHR could reduce the enzymatic activity of OXPHOS complexes in DF-1 cells.

2.6. Knockdown of GHR Impaired Mitochondrial Function in DF-1 Cells

In order to further investigate whether the knockdown of GHR could cause mitochondrial dysfunction in DF-1 cells, we assessed mitochondrial function in GHR knockdown cells. ΔΨm was significantly reduced (Figure 6A) and accompanied by a significant increase of mitochondrial swelling (Figure 6C) in GHR knockdown cells. Reactive oxygen species production was significantly increased (Figure 6B) and accompanied by a significant increase of MDA level (Figure 6D) and a significant reduction of ATP level (Figure 6E) in GHR knockdown cells. Consistently, RCR was significantly reduced in GHR knockdown cells (Figure 6F). As a result, we demonstrated that the knockdown of GHR impaired mitochondrial function in DF-1 cells.

2.7. Knockdown of GHR Altered Mitochondrial Structure and Reduced Mitochondrial Number in DF-1 Cells

Considering that the morphology and structure of mitochondria lays the foundation for mitochondrial function, we assessed them by TEM at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. We found some alterations in structure of mitochondria in GHR knockdown cells (see arrows), including increased mitochondrial vacuolation, absence of dense matrix granules and disappearance of mitochondria cristae (Figure 7A). We also found that knockdown of GHR could significantly reduce mitochondrial number and the ratio of mitochondria to cytosol volume in DF-1 cells by TEM (Figure 7B,C). In order to verify the consequences of TEM, we then labeled the mitochondria by MitoTracker staining, in which fluorescence intensity represented the mitochondrial mass [17]. The mitochondrial mass was significantly reduced in GHR knockdown cells, which was consistent with the result of TEM (Figure 7D–F). In summary, we demonstrated that knockdown of GHR could reduce mitochondrial number and alter mitochondrial structure in DF-1 cells.

3. Discussion

Growth hormone can bind to GHR to regulate IGF-1 production through the JAK–STAT pathway [18]. The mutation in GHR in SLD chickens interferes with the binding between GH and GHR, and further disrupts the GH–GHR–IGF1 signaling pathway, accompanied by low levels of IGF-1 [19]. A previous study has reported that compared with aging rats that had been administrated with exogenous IGF-1, untreated aging rats showed significant mitochondrial dysfunction [20], indicating that the level of IGF1 is essential for mammalian mitochondrial function. In this study, we found that the relative mRNA expression of IGF1 was significantly downregulated in both SLD chickens and GHR knockdown cells, indicating the low level of GH binding activity and IGF-1 production. These results further prompted us to investigate mitochondrial function in SLD chicken skeletal muscle and in GHR knockdown cells.
Mitochondrial biogenesis, a dynamically regulated process, is mainly regulated by nuclear genes through the PGC1α–NRF1–TFAM signaling pathway [4]. The activity of PGC1α is related to its expression level [21], and the low expression of PGC1α is associated with mitochondrial dysfunction in human skeletal muscle [22]. PGC1α can regulate expression of TFAM, and the overexpression of TFAM can stimulate mitochondrial biogenesis in mice fibroblast cells [23]. The role of TFAM has been highlighted by regulating the transcription of mtDNA-encoded genes in human skeletal muscle [24]. Our results are consistent with these findings in mammals because we also found that the relative mRNA expression of PGC1α, TFAM and mtDNA-encoded OXPHOS genes were all downregulated in SLD chicken skeletal muscle and GHR knockdown cells. Furthermore, there is evidence of low expression of PGC1α and reduced enzymatic activity of OXPHOS complexes in the skeletal muscle of GH-deficient Ames mice [7], and downregulated relative mRNA expression of NRF1 and TFAM in the skeletal muscle of GHRKO mice [8]. These findings are also consistent with our results, in which we observed the low expression of genes involved in the PGC1α–NRF1–TFAM signaling pathway and reduced enzymatic activity of OXPHOS complexes in SLD chicken skeletal muscle. However, our results show that the enzymatic activity of complexes I, II, III and IV was reduced by 26%, 45%, 53% and 72% in SLD chicken skeletal muscle, respectively, while in GHR knockdown cells the enzymatic activity was reduced by 53%, 34%, 36% and 25%, respectively, that means an exactly opposite trend. This is probably due to the mutation in GHR in vivo that is different from the interference with GHR in vitro. The mutation in GHR completely alters the function of the GHR in vivo, which might lead to a larger impact on the activity of complex IV. As the interference with GHR cannot completely inhibit the function of the GHR in vitro, which might primarily affect the activity of complex I, we argue that the regulatory mechanism of the enzymatic activities of OXPHOS complexes might be different between SLD chicken skeletal muscle and GHR knockdown cells.
Impaired mitochondrial biogenesis and inhibited mtDNA transcription will further lead to mitochondrial dysfunction in mammals [25]. ΔΨm is essential for mitochondrial function; loss of ΔΨm indicates mitochondrial dysfunction [26] and is normally accompanied by increased mitochondrial swelling [27]. Reduced ΔΨm may lead to uncoupling of OXPHOS, and the impairment of OXPHOS complex activities may increase ROS production accompanied by elevated MDA levels and reduced ATP levels [28]. Meanwhile, RCR is a sensitive indicator of mitochondrial respiratory function [29]. In cases of hepatic mitochondrial dysfunction in a murine model of peanut allergy, decreased RCR can be observed with a simultaneous increase in ROS production [30]. Here, we found that reduced ΔΨm, increased mitochondrial swelling, excessive ROS production, elevated MDA levels, reduced ATP levels and decreased RCR were observed in SLD chicken skeletal muscle and GHR knockdown cells. Our results are in line with previous studies in mammals showing that the function of mitochondria is compromised in GHRKO osteocytes [31] and inhibition of IGF1 signaling leads to mitochondrial dysfunction in cancer cells [11]. Therefore, we argue that the low expression of IGF1 might cause mitochondrial dysfunction by regulating mitochondrial biogenesis through the PGC1α–NRF1–TFAM signaling pathway in poultry.
In addition, the morphology and structure of mitochondria are essential for mitochondrial function and cell homeostasis [32]. The results of this study showed that knockdown of GHR and the accompanying low expression of IGF1 could reduce the number of mitochondria and alter the structure of mitochondria, as observed in DF-1 cells as increased mitochondrial vacuolation, an absence of dense matrix granules and the disappearance of mitochondria cristae. Our results are in agreement with a previous study showing that a change in IGF1 signaling could alter the morphology and structure of mitochondria in mice Leydig cells [10].
In conclusion, we demonstrated for the first time that the function of mitochondria was impaired in SLD chicken skeletal muscle and GHR knockdown cells, and knockdown of GHR can reduce mitochondrial number and alter the structure of mitochondria in DF-1 cells. We conclude that the GHR gene is essential for chicken mitochondrial function both in vivo and in vitro.

4. Materials and Methods

4.1. Ethics Statement

All animal experiments in this study were performed according to the protocols approved by the South China Agriculture University Institutional Animal Care and Use Committee (approval number: SCAU#0015). All animal procedures followed the regulations and guidelines established by this committee and minimized the suffering of animals.

4.2. Animals

In this study, we used 7-week-old female SLD chickens in strain N301 as the experimental group, and this strain is characterized by a T354C mutation in exon 5 of GHR as previously described [14]. Meanwhile, we used normal 7-week-old female chickens in strain N202 as a control group, which have a wild-type GHR gene. Here, we used gastrocnemius muscle in SLD chickens to assess the role of GHR in chicken mitochondrial function in vivo. All chickens were obtained from the WenShi Group Co., Ltd. (Guangdong, China).

4.3. Cell Culture and RNA Interference

In this study, we interfered with the expression of GHR using a chicken embryo fibroblast (DF-1) cell line to assess the role of GHR in chicken mitochondrial function in vitro. The DF-1 cells were cultured in high-glucose Dulbecco’s modified Eagle’s medium (Gibco, NY, USA) with 10% fetal bovine serum (Hyclone, UT, USA) and 0.2% penicillin/streptomycin (Invitrogen, CA, USA). The DF-1 cells were plated on a culture plate and incubated overnight prior to the transfection experiment. The siRNAs used for the knockdown of GHR were synthesized by Guangzhou RiboBio (Guangzhou, China). In our preliminary experiments, we designed four siRNA to interfere with GHR and used the si-GHR with the highest interference efficiency. The sequence of si-GHR was 5′-CCUCGAUUUGGAUACCAUA-3′. si-GHR and si-NC were transfected in DF-1 cells to a final concentration of 20 nM using Lipofectamine 3000 reagent (Invitrogen, CA, USA) according to the manufacturer’s protocol, and cells were analyzed at 48 h after transfection. The GHR inhibition efficiencies were detected by the fluorescence intensity of FAM siRNA and qRT-PCR.

4.4. Quantitative Real-Time PCR

Total RNA was extracted from gastrocnemius muscle or cells with RNAiso reagent (Takara, Japan) according to the manufacturer’s protocol. The RNA integrity and concentration were determined using 1.5% agarose gel electrophoresis and a Nanodrop 2000c spectrophotometer (Thermo, USA), respectively. cDNA was synthesized using PrimeScript RT Reagent Kit (Takara, Japan) for qRT-PCR. The MonAmp™ ChemoHS qPCR Mix (Monad Co., LTD Guangzhou, China) was used for quantitative real-time PCR (qRT-PCR) in a Bio-Rad CFX96 Real-Time Detection instrument (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s protocol. Relative gene expression was measured by qRT-PCR twice for each reaction and the nuclear gene β-actin was used as a control. The primers used in qRT-PCR are shown in Table S1.

4.5. Transmission Electron Microscopy

TEM was used to determine the morphology and structure of mitochondria. Cells were fixed in 2.5% glutaraldehyde for 4 h at 4 °C and then cultured as previously described [16]. A transmission electron microscope (Hitachi HT7700, Tokyo, Japan) was used to examine and photograph mitochondria, and five randomly selected areas were photographed at 2500× magnification and counted as previously reported [33].

4.6. MitoTracker Green Staining and Hoechst 33342 Staining

MitoTracker Green staining and Hoechst 33342 staining was used to label the mitochondria and nuclei in DF-1 cells, respectively. Cells were washed twice with PBS and incubated with MitoTracker Green (Beyotime, Shanghai, China) for 30 min at 48 h after transfection. Cells were then suspended in PBS and 10 μL of Hoechst 33342 dye was added (Beyotime, Shanghai, China). After being washed in PBS twice, a fluorescence microscope (Nikon TE2000-U, Tokyo, Japan) was used to capture five randomly selected fields and analyzed with NIS-Elements software.

4.7. Mitochondria Isolation and Mitochondrial Protein Concentration Measurement

The mitochondria of gastrocnemius muscle and DF-1 cells were isolated using mitochondrial extraction kits (C3606, C3601; Beyotime, Shanghai, China) according to the manufacturer’s protocol, as previously described [34]. Mitochondrial protein concentration was measured by BCA protein assay to normalize the protein content as previously described [35].

4.8. Measurement of Enzymatic Activity of Mitochondrial OXPHOS Complexes

Gastrocnemius muscle was dissected and immediately frozen in liquid nitrogen, and then stored at −80 °C [36]. We used commercial assay kits (BC0515, BC3235, BC3245, BC0945; Solarbio, Beijing, China) to measure the enzyme activity of mitochondrial OXPHOS complexes of gastrocnemius muscle and DF-1 cells according to the manufacturer’s protocol. Complex I enzyme activity was determined by the change in absorbance of NADH as measured at 340 nm. Complex II enzyme activity was determined by the change in absorbance of DCIP as measured at 600 nm. The enzyme activity of complex III and complex IV was determined by the change in absorbance of reduced cytochrome c as measured at 550 nm. Absorbance was determined using a Fluorescence/Multi-Detection Microplate Reader (BioTek, Winooski, VT, USA) according to the manufacturer’s protocol. Data were normalized to the control group and expressed as a percentage of control levels.

4.9. Measurement of Adenosine Triphosphate Level

The ATP level was measured using an ATP assay kit (S0026; Beyotime, Shanghai, China) according to the manufacturer’s protocol. A Fluorescence/Multi-Detection Microplate Reader (BioTek, USA) was used to determine the ATP level in gastrocnemius muscle and cells as previously described [37]. Data were normalized to the control group and expressed as a percentage of control levels.

4.10. Measurement of Malondialdehyde Level

The MDA level was measured using an MDA assay kit (S0131; Beyotime, Shanghai, China) according to the manufacturer’s protocol. The supernatants of gastrocnemius muscle mitochondria and cell lysis were incubated with MDA reagent for 40 min at 95 °C. Absorbance was determined using a Fluorescence/Multi-Detection Microplate Reader (BioTek, USA). Data were normalized to the control group and expressed as a percentage of control levels.

4.11. Measurement of Mitochondrial Membrane Potential

Mitochondrial membrane potential was measured using a JC-1 kit (C2005; Beyotime, Shanghai, China) according to the manufacturer’s protocol. Gastrocnemius muscle mitochondria were fixed with JC-1. The fluorescence was determined using a Fluorescence/Multi-Detection Microplate Reader (BioTek, USA) and DF-1 cells were incubated with JC-1 for 20 min at 37 °C. After washing in PBS twice, the fluorescence was determined using a flow cytometer (BD Biosciences, San Jose, CA, USA), and 10 µM rotenone was used as standard inhibitor of ΔΨm. The ΔΨm of mitochondria were represented as the ratio of aggregated and monomeric JC-1, and data were normalized to the control group and expressed as a percentage of control levels.

4.12. Measurement of Mitochondrial Swelling

Mitochondrial swelling was measured by the absorbance at 540 nm, as previously described [38]. A decrease in absorbance indicates an increase in mitochondrial swelling. Mitochondria were freshly isolated from gastrocnemius muscle and DF-1 cells, and absorbance was determined using a Fluorescence/Multi-Detection Microplate Reader (BioTek, USA). Data were normalized to the control group and expressed as a percentage of control levels.

4.13. Measurement of Reactive Oxygen Species Production

Reactive oxygen species production of gastrocnemius muscle mitochondria was determined using the rate of NBT reduction at 595 nm, as previously described [39]. Absorbance was determined using a Fluorescence/Multi-Detection Microplate Reader (BioTek, USA). Reactive oxygen species production in the mitochondria of DF-1 cells was measured using a ROS Assay Kit (S0033; Beyotime, Shanghai, China) according to the manufacturer’s protocol. Cells were incubated with 10 mM DCFH-DA probes at 37 °C for 20 min and washed twice with PBS. Dichlorofluorescein (DCF) fluorescence was determined using a Fluorescence/Multi-Detection Microplate Reader (BioTek, USA), and the images of cells were taken by a fluorescence microscope (Nikon TE2000-U, Japan). Data were normalized to the control group and expressed as a percentage of control levels.

4.14. Measurement of Mitochondrial Respiratory Control Ratio

Mitochondrial respiratory control ratio was measured using an RCR kit (GMS10097; GenMed Scientifics Inc., MA, USA) according to the manufacturer’s protocol, as previously described [29]. Oxygen consumption of mitochondria protein was measured using a Clarke-type oxygen electrode (Hansatech Oxytherm, Norfolk, UK). The RCR was represented as the ratio of state III to state IV respiration rate. Data were normalized to the control group and expressed as a percentage of control levels.

4.15. Statistical Analysis

All experiments were performed at least three times. The data were presented as means ± standard error of the mean (SEM), the statistical analyses were performed using Student’s t-test, and the significance was represented by p-values. p < 0.05 was considered to be statistically significant, * p < 0.05, ** p < 0.01, *** p < 0.001.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/20/7/1608/s1.

Author Contributions

B.H. designed the study, wrote the paper, carried out experiments, and analyzed data. S.H. participated in data collection and interpretation, and helped with performing some of the manuscript’s experiments. M.Y., Z.L. helped with performing some of the manuscript’s experiments. Q.L., D.Z. helped by providing useful discussion and language correction. H.L., X.Z. participated in the design, manuscript writing and final approval of the manuscript. All authors read and approved the final manuscript.

Funding

This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31401046), the China Agriculture Research System (CARS-41-G03), and Guangdong Youth Talent Project.

Conflicts of Interest

The authors declare that they have no conflict of interest.

References

  1. Rahman, J.; Rahman, S. Mitochondrial medicine in the omics era. Lancet 2018, 391, 2560–2574. [Google Scholar] [CrossRef]
  2. Calvo, S.E.; Clauser, K.R.; Mootha, V.K. MitoCarta2.0: An updated inventory of mammalian mitochondrial proteins. Nucleic Acids Res. 2016, 44, D1251–D1257. [Google Scholar] [CrossRef]
  3. Boore, J.L. Animal mitochondrial genomes. Nucleic Acids Res. 1999, 27, 1767–1780. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Zhu, J.; Wang, K.Z.; Chu, C.T. After the banquet: Mitochondrial biogenesis, mitophagy, and cell survival. Autophagy 2013, 9, 1663–1676. [Google Scholar] [CrossRef]
  5. Scarpulla, R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88, 611–638. [Google Scholar] [CrossRef] [PubMed]
  6. Perret-Vivancos, C.; Abbate, A.; Ardail, D.; Raccurt, M.; Usson, Y.; Lobie, P.E.; Morel, G. Growth hormone activity in mitochondria depends on GH receptor Box 1 and involves caveolar pathway targeting. Exp. Cell Res. 2006, 312, 215–232. [Google Scholar]
  7. Brown-Borg, H.M.; Johnson, W.T.; Rakoczy, S.G. Expression of oxidative phosphorylation components in mitochondria of long-living Ames dwarf mice. Age 2012, 34, 43–57. [Google Scholar] [CrossRef]
  8. Gesing, A.; Masternak, M.M.; Wang, F.; Joseph, A.M.; Leeuwenburgh, C.; Westbrook, R.; Lewinski, A.; Karbownik-Lewinska, M.; Bartke, A. Expression of key regulators of mitochondrial biogenesis in growth hormone receptor knockout (GHRKO) mice is enhanced but is not further improved by other potential life-extending interventions. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66, 1062–1076. [Google Scholar] [CrossRef]
  9. Zawada, I.; Masternak, M.M.; List, E.O.; Stout, M.B.; Berryman, D.E.; Lewinski, A.; Kopchick, J.J.; Bartke, A.; Karbownik-Lewinska, M.; Gesing, A. Gene expression of key regulators of mitochondrial biogenesis is sex dependent in mice with growth hormone receptor deletion in liver. Aging 2015, 7, 195–204. [Google Scholar] [CrossRef] [Green Version]
  10. Radovic, S.M.; Starovlah, I.M.; Cap, I.; Miljkovic, D.; Nef, S.; Kostic, T.S.; Andric, S.A. Insulin/IGF1 signalling regulates the mitochondrial biogenesis markers in steroidogenic cells of prepubertal testis, but not ovary. Biol. Reprod. 2019, 100, 253–267. [Google Scholar] [CrossRef]
  11. Lyons, A.; Coleman, M.; Riis, S.; Favre, C.; O’Flanagan, C.H.; Zhdanov, A.V.; Papkovsky, D.B.; Hursting, S.D.; O’Connor, R. Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells. J. Biol. Chem. 2017, 292, 16983–16998. [Google Scholar] [CrossRef]
  12. Tahara, K.; Tsukada, A.; Hanai, T.; Okumura, K.; Yamada, K.; Murai, A.; Yamamoto, R.; Maeno, M.; Saito, N.; Shimada, K. Identification of two types of growth hormone receptor mutations in two strains of sex-linked dwarf chickens. J. Poult. Sci. 2009, 46, 249–256. [Google Scholar] [CrossRef]
  13. Agarwal, S.K.; Cogburn, L.A.; Burnside, J. Comparison of gene expression in normal and growth hormone receptor-deficient dwarf chickens reveals a novel growth hormone regulated gene. Biochem. Biophys. Res. Commun. 1995, 206, 153–160. [Google Scholar] [CrossRef] [PubMed]
  14. Ouyang, J.H.; Xie, L.; Nie, Q.H.; Zeng, H.; Peng, Z.J.; Zhang, D.X.; Zhang, X.Q. The effects of different Sex-Linked dwarf variations on chinese native chickens. J. Integr. Agr. 2012, 11, 1500–1508. [Google Scholar] [CrossRef]
  15. Knizetova, H. Effects of the sex-linked dwarf gene (dw) on skeletal muscle cellularity in broiler chickens. Br. Poult. Sci. 1993, 34, 479–485. [Google Scholar] [CrossRef] [PubMed]
  16. Luo, W.; Lin, S.; Li, G.; Nie, Q.; Zhang, X. Integrative analyses of miRNA-mRNA interactions reveal let-7b, miR-128 and MAPK pathway involvement in muscle mass loss in Sex-Linked dwarf chickens. Int. J. Mol. Sci. 2016, 17, 276. [Google Scholar] [CrossRef] [PubMed]
  17. Xu, F.; Yu, H.; Liu, J.; Cheng, L. Pyrroloquinoline quinone inhibits oxygen/glucose deprivation-induced apoptosis by activating the PI3K/AKT pathway in cardiomyocytes. Mol. Cell Biochem. 2014, 386, 107–115. [Google Scholar] [CrossRef] [PubMed]
  18. Junnila, R.K.; List, E.O.; Berryman, D.E.; Murrey, J.W.; Kopchick, J.J. The GH/IGF-1 axis in ageing and longevity. Nat. Rev. Endocrinol. 2013, 9, 366–376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Lin, S.; Li, H.; Mu, H.; Luo, W.; Li, Y.; Jia, X.; Wang, S.; Jia, X.; Nie, Q.; Li, Y.; et al. Let-7b regulates the expression of the growth hormone receptor gene in deletion-type dwarf chickens. BMC Genomics 2012, 13, 306. [Google Scholar] [CrossRef]
  20. Puche, J.E.; Garcia-Fernandez, M.; Muntane, J.; Rioja, J.; Gonzalez-Baron, S.; Castilla, C.I. Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. Endocrinology 2008, 149, 2620–2627. [Google Scholar] [CrossRef] [PubMed]
  21. Safdar, A.; Little, J.P.; Stokl, A.J.; Hettinga, B.P.; Akhtar, M.; Tarnopolsky, M.A. Exercise increases mitochondrial PGC-1alpha content and promotes nuclear-mitochondrial cross-talk to coordinate mitochondrial biogenesis. J. Biol. Chem. 2011, 286, 10605–10617. [Google Scholar] [CrossRef] [PubMed]
  22. Joseph, A.M.; Adhihetty, P.J.; Buford, T.W.; Wohlgemuth, S.E.; Lees, H.A.; Nguyen, L.M.; Aranda, J.M.; Sandesara, B.D.; Pahor, M.; Manini, T.M.; et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell 2012, 11, 801–809. [Google Scholar] [CrossRef] [PubMed]
  23. Thomas, R.R.; Khan, S.M.; Portell, F.R.; Smigrodzki, R.M.; Bennett, J.J. Recombinant human mitochondrial transcription factor a stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin. Mitochondrion 2011, 11, 108–118. [Google Scholar] [CrossRef] [PubMed]
  24. Collu-Marchese, M.; Shuen, M.; Pauly, M.; Saleem, A.; Hood, D.A. The regulation of mitochondrial transcription factor a (Tfam) expression during skeletal muscle cell differentiation. Biosci. Rep. 2015, 35, e00221. [Google Scholar] [CrossRef]
  25. Golpich, M.; Amini, E.; Mohamed, Z.; Azman, A.R.; Mohamed, I.N.; Ahmadiani, A. Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: Pathogenesis and treatment. CNS Neurosci. Ther. 2017, 23, 5–22. [Google Scholar] [CrossRef]
  26. Javadov, S.; Baetz, D.; Rajapurohitam, V.; Zeidan, A.; Kirshenbaum, L.A.; Karmazyn, M. Antihypertrophic effect of Na+/H+ exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species. J. Pharmacol. Exp. Ther. 2006, 317, 1036–1043. [Google Scholar] [CrossRef] [PubMed]
  27. Javadov, S.; Karmazyn, M.; Escobales, N. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J. Pharmacol. Exp. Ther. 2009, 330, 670–678. [Google Scholar] [CrossRef]
  28. Bai, F.; Guo, F.; Jiang, T.; Wei, H.; Zhou, H.; Yin, H.; Zhong, H.; Xiong, L.; Wang, Q. Arachidonyl-2-chloroethylamide alleviates cerebral ischemia injury through glycogen synthase kinase-3beta-mediated mitochondrial biogenesis and functional improvement. Mol. Neurobiol. 2017, 54, 1240–1253. [Google Scholar] [CrossRef]
  29. Su, Y.; Zhu, L.; Yu, X.; Cai, L.; Lu, Y.; Zhang, J.; Li, T.; Li, J.; Xia, J.; Xu, F.; et al. Mitochondrial transplantation attenuates airway hyperresponsiveness by inhibition of cholinergic hyperactivity. Theranostics 2016, 6, 1244–1260. [Google Scholar] [CrossRef]
  30. Trinchese, G.; Paparo, L.; Aitoro, R.; Fierro, C.; Varchetta, M.; Nocerino, R.; Mollica, M.P.; Berni, C.R. Hepatic mitochondrial dysfunction and immune response in a murine model of peanut allergy. Nutrients 2018, 10, 744. [Google Scholar] [CrossRef]
  31. Liu, Z.; Solesio, M.E.; Schaffler, M.B.; Frikha-Benayed, D.; Rosen, C.J.; Werner, H.; Kopchick, J.J.; Pavlov, E.V.; Abramov, A.Y.; Yakar, S. Mitochondrial function is compromised in cortical bone osteocytes of Long-Lived growth hormone receptor null mice. J. Bone Miner. Res. 2019, 34, 106–122. [Google Scholar] [CrossRef] [PubMed]
  32. Rambold, A.S.; Lippincott-Schwartz, J. Mechanisms of mitochondria and autophagy crosstalk. Cell Cycle 2011, 10, 4032–4038. [Google Scholar] [CrossRef] [Green Version]
  33. Xie, Y.; Li, J.; Fan, G.; Qi, S.; Li, B. Reperfusion promotes mitochondrial biogenesis following focal cerebral ischemia in rats. PLoS ONE 2014, 9, e92443. [Google Scholar] [CrossRef]
  34. Zhu, Y.; Di, S.; Hu, W.; Feng, Y.; Zhou, Q.; Gong, B.; Tang, X.; Liu, J.; Zhang, W.; Xi, M.; et al. A new flavonoid glycoside (APG) isolated from Clematis tangutica attenuates myocardial ischemia/reperfusion injury via activating PKCepsilon signaling. Biochim. Biophys. Acta 2017, 1863, 701–711. [Google Scholar] [CrossRef] [PubMed]
  35. Sheng, B.; Gong, K.; Niu, Y.; Liu, L.; Yan, Y.; Lu, G.; Zhang, L.; Hu, M.; Zhao, N.; Zhang, X.; et al. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer’s disease. Free Radic. Biol. Med. 2009, 46, 1362–1375. [Google Scholar] [CrossRef]
  36. Thorburn, D.R.; Chow, C.W.; Kirby, D.M. Respiratory chain enzyme analysis in muscle and liver. Mitochondrion 2004, 4, 363–375. [Google Scholar] [CrossRef]
  37. Shen, Z.; Zheng, Y.; Wu, J.; Chen, Y.; Wu, X.; Zhou, Y.; Yuan, Y.; Lu, S.; Jiang, L.; Qin, Z.; et al. PARK2-dependent mitophagy induced by acidic postconditioning protects against focal cerebral ischemia and extends the reperfusion window. Autophagy 2017, 13, 473–485. [Google Scholar] [CrossRef] [Green Version]
  38. Zamzami, N.; Maisse, C.; Metivier, D.; Kroemer, G. Measurement of membrane permeability and permeability transition of mitochondria. Methods Cell Biol. 2001, 65, 147–158. [Google Scholar]
  39. Kim, T.S.; Yun, B.Y.; Kim, I.Y. Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide. Biochem. Pharmacol. 2003, 66, 2301–2311. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Low expression of key regulators of mitochondrial biogenesis and mtDNA-encoded oxidative phosphorylation (OXPHOS) genes in sex-linked dwarf (SLD) chicken skeletal muscle. (A) The relative mRNA expression of genes involved in the GH–GHR–IGF1 signaling pathway was measured by qRT-PCR in SLD chicken skeletal muscle as compared with normal chicken skeletal muscle. (B) The relative mRNA expression involved in the PGC1α–NRF1–TFAM signaling pathway was measured by qRT-PCR in SLD chicken skeletal muscle as compared with normal chicken skeletal muscle. (C) The relative mRNA expression of mtDNA-encoded OXPHOS genes was measured by qRT-PCR in SLD chicken skeletal muscle as compared with normal chicken skeletal muscle. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 1. Low expression of key regulators of mitochondrial biogenesis and mtDNA-encoded oxidative phosphorylation (OXPHOS) genes in sex-linked dwarf (SLD) chicken skeletal muscle. (A) The relative mRNA expression of genes involved in the GH–GHR–IGF1 signaling pathway was measured by qRT-PCR in SLD chicken skeletal muscle as compared with normal chicken skeletal muscle. (B) The relative mRNA expression involved in the PGC1α–NRF1–TFAM signaling pathway was measured by qRT-PCR in SLD chicken skeletal muscle as compared with normal chicken skeletal muscle. (C) The relative mRNA expression of mtDNA-encoded OXPHOS genes was measured by qRT-PCR in SLD chicken skeletal muscle as compared with normal chicken skeletal muscle. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Ijms 20 01608 g001
Figure 2. Reduced enzymatic activity of OXPHOS complexes in SLD chicken skeletal muscle. (A) Enzymatic activity of complex I was measured by the change in absorbance of NADH in SLD and normal chicken skeletal muscle. (B) Enzymatic activity of complex II was measured by the change in absorbance of DCIP in SLD and normal chicken skeletal muscle. (C) Enzymatic activity of complex III was measured by the change in absorbance of reduced cytochrome c in SLD and normal chicken skeletal muscle. (D) Enzymatic activity of complex IV was measured by the change in absorbance of reduced cytochrome c in SLD and normal chicken skeletal muscle. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 2. Reduced enzymatic activity of OXPHOS complexes in SLD chicken skeletal muscle. (A) Enzymatic activity of complex I was measured by the change in absorbance of NADH in SLD and normal chicken skeletal muscle. (B) Enzymatic activity of complex II was measured by the change in absorbance of DCIP in SLD and normal chicken skeletal muscle. (C) Enzymatic activity of complex III was measured by the change in absorbance of reduced cytochrome c in SLD and normal chicken skeletal muscle. (D) Enzymatic activity of complex IV was measured by the change in absorbance of reduced cytochrome c in SLD and normal chicken skeletal muscle. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Ijms 20 01608 g002
Figure 3. Impaired mitochondrial function in SLD chicken skeletal muscle. (A) Mitochondrial ΔΨm was measured by the fluorescence of JC-1 in SLD and normal chicken skeletal muscle. Red fluorescence represents aggregation of JC-1, green fluorescence represents monomeric JC-1, and ΔΨm was represented as the ratio of aggregated and monomeric JC-1. (B) Mitochondrial swelling was measured by the absorbance at 540 nm of mitochondria isolated from SLD and normal chicken skeletal muscle. (C) Reactive oxygen species (ROS) production was measured by the fluorescence of dichlorofluorescein (DCF) in SLD and normal chicken skeletal muscle. The level of (D) malondialdehyde (MDA) and (E) ATP were measured in SLD and normal chicken skeletal muscle. (F) Mitochondrial respiratory control ratio (RCR) was calculated as the ratio of state III to state IV respiration rate in SLD and normal chicken skeletal muscle. Data are expressed as means ± SEM, *p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 3. Impaired mitochondrial function in SLD chicken skeletal muscle. (A) Mitochondrial ΔΨm was measured by the fluorescence of JC-1 in SLD and normal chicken skeletal muscle. Red fluorescence represents aggregation of JC-1, green fluorescence represents monomeric JC-1, and ΔΨm was represented as the ratio of aggregated and monomeric JC-1. (B) Mitochondrial swelling was measured by the absorbance at 540 nm of mitochondria isolated from SLD and normal chicken skeletal muscle. (C) Reactive oxygen species (ROS) production was measured by the fluorescence of dichlorofluorescein (DCF) in SLD and normal chicken skeletal muscle. The level of (D) malondialdehyde (MDA) and (E) ATP were measured in SLD and normal chicken skeletal muscle. (F) Mitochondrial respiratory control ratio (RCR) was calculated as the ratio of state III to state IV respiration rate in SLD and normal chicken skeletal muscle. Data are expressed as means ± SEM, *p < 0.05; ** p < 0.01; *** p < 0.001.
Ijms 20 01608 g003
Figure 4. Knockdown of GHR reduced the GH binding activity and downregulated the expression of key regulators of mitochondrial biogenesis and mtDNA-encoded genes in DF-1 cells. (A) Transfection efficiency was measured by the fluorescence intensity of FAM siRNA and qRT-PCR at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Bar, 100 μm. The relative mRNA expression of genes involved in the GH–GHR–IGF1 signaling pathway (B) and PGC1α–NRF1–TFAM signaling pathway (C) were measured by qRT-PCR at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (D) mtDNA transcription was measured by qRT-PCR at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 4. Knockdown of GHR reduced the GH binding activity and downregulated the expression of key regulators of mitochondrial biogenesis and mtDNA-encoded genes in DF-1 cells. (A) Transfection efficiency was measured by the fluorescence intensity of FAM siRNA and qRT-PCR at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Bar, 100 μm. The relative mRNA expression of genes involved in the GH–GHR–IGF1 signaling pathway (B) and PGC1α–NRF1–TFAM signaling pathway (C) were measured by qRT-PCR at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (D) mtDNA transcription was measured by qRT-PCR at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Ijms 20 01608 g004
Figure 5. Knockdown of GHR reduced the enzymatic activity of OXPHOS complexes in DF-1 cells. (A) Enzymatic activity of complex I was measured by the change in absorbance of NADH at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (B) Enzymatic activity of complex II was measured by the change in absorbance of DCIP at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (C) Enzymatic activity of complex III was measured by the change in absorbance of reduced cytochrome c at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (D) Enzymatic activity of complex IV was measured by the change in absorbance of reduced cytochrome c at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 5. Knockdown of GHR reduced the enzymatic activity of OXPHOS complexes in DF-1 cells. (A) Enzymatic activity of complex I was measured by the change in absorbance of NADH at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (B) Enzymatic activity of complex II was measured by the change in absorbance of DCIP at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (C) Enzymatic activity of complex III was measured by the change in absorbance of reduced cytochrome c at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (D) Enzymatic activity of complex IV was measured by the change in absorbance of reduced cytochrome c at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Ijms 20 01608 g005
Figure 6. Knockdown of GHR caused mitochondrial dysfunction in DF-1 cells. (A) Mitochondrial ΔΨm was measured by the fluorescence of JC-1 at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Red fluorescence represents aggregation of JC-1, green fluorescence represents monomeric JC-1, ΔΨm was represented as the ratio of aggregated and monomeric JC-1. (B) Reactive oxygen species production was measured by the fluorescence of DCF at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Bar, 100 μm. (C) Mitochondrial swelling was measured by the absorbance at 540 nm after transfection with si-GHR and si-NC fragments in DF-1 cells. The level of (D) MDA and (E) ATP were measured at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (F) Respiratory control ratio was calculated as the ratio of state III to state IV respiration rate at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 6. Knockdown of GHR caused mitochondrial dysfunction in DF-1 cells. (A) Mitochondrial ΔΨm was measured by the fluorescence of JC-1 at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Red fluorescence represents aggregation of JC-1, green fluorescence represents monomeric JC-1, ΔΨm was represented as the ratio of aggregated and monomeric JC-1. (B) Reactive oxygen species production was measured by the fluorescence of DCF at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Bar, 100 μm. (C) Mitochondrial swelling was measured by the absorbance at 540 nm after transfection with si-GHR and si-NC fragments in DF-1 cells. The level of (D) MDA and (E) ATP were measured at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. (F) Respiratory control ratio was calculated as the ratio of state III to state IV respiration rate at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Ijms 20 01608 g006
Figure 7. Knockdown of GHR altered mitochondrial structure and reduced mitochondrial number in DF-1 cells. (A) Mitochondrial ultrastructure was imaged by TEM at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells, and abnormal mitochondria are indicated by black arrows. (B) The number of mitochondria and (C) the ratio of mitochondria to cytosol volume as determined from TEM images were assessed in DF-1 cells (n = 5). (D) MitoTracker staining of DF-1 cells was measured at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Bar, 100 μm. (E) Fluorescence intensity of MitoTracker staining and (F) average cell fluorescence intensity of MitoTracker staining were assessed in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 7. Knockdown of GHR altered mitochondrial structure and reduced mitochondrial number in DF-1 cells. (A) Mitochondrial ultrastructure was imaged by TEM at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells, and abnormal mitochondria are indicated by black arrows. (B) The number of mitochondria and (C) the ratio of mitochondria to cytosol volume as determined from TEM images were assessed in DF-1 cells (n = 5). (D) MitoTracker staining of DF-1 cells was measured at 48 h after transfection with si-GHR and si-NC fragments in DF-1 cells. Bar, 100 μm. (E) Fluorescence intensity of MitoTracker staining and (F) average cell fluorescence intensity of MitoTracker staining were assessed in DF-1 cells. Data are expressed as means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001.
Ijms 20 01608 g007

Share and Cite

MDPI and ACS Style

Hu, B.; Hu, S.; Yang, M.; Liao, Z.; Zhang, D.; Luo, Q.; Zhang, X.; Li, H. Growth Hormone Receptor Gene is Essential for Chicken Mitochondrial Function In Vivo and In Vitro. Int. J. Mol. Sci. 2019, 20, 1608. https://doi.org/10.3390/ijms20071608

AMA Style

Hu B, Hu S, Yang M, Liao Z, Zhang D, Luo Q, Zhang X, Li H. Growth Hormone Receptor Gene is Essential for Chicken Mitochondrial Function In Vivo and In Vitro. International Journal of Molecular Sciences. 2019; 20(7):1608. https://doi.org/10.3390/ijms20071608

Chicago/Turabian Style

Hu, Bowen, Shuang Hu, Minmin Yang, Zhiying Liao, Dexiang Zhang, Qingbin Luo, Xiquan Zhang, and Hongmei Li. 2019. "Growth Hormone Receptor Gene is Essential for Chicken Mitochondrial Function In Vivo and In Vitro" International Journal of Molecular Sciences 20, no. 7: 1608. https://doi.org/10.3390/ijms20071608

APA Style

Hu, B., Hu, S., Yang, M., Liao, Z., Zhang, D., Luo, Q., Zhang, X., & Li, H. (2019). Growth Hormone Receptor Gene is Essential for Chicken Mitochondrial Function In Vivo and In Vitro. International Journal of Molecular Sciences, 20(7), 1608. https://doi.org/10.3390/ijms20071608

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop